Horowitz: Did 7.5 million people die from COVID

New Post Public Reply Private Reply Replies (0) Message Board
energy_wave energy_wave #44537
275
Horowitz: Did 7.5 million people die from COVID shots?
Daniel Horowitz


Quote:
There is simply no macro epidemiological evidence that the COVID jabs saved any lives from the virus. To the contrary, there are numerous data points showing negative efficacy. Moreover, over 70% of the 6.75 million recorded COVID deaths occurred precisely after the shots were unleashed. In fact, many parts of the world that barely experienced COVID deaths during the first year, such as Scandinavia, Australia, and far East Asia, incurred almost all of their deaths after the shots were in the arms of every senior. So now that we established there was no mortality benefit, what was the cost? What if I told you it was 7.5 million – even more than the recorded number of COVID deaths?

A new peer-reviewed study from Michigan State University estimated that as of Dec. 18, 2021, the time of the survey, 278,000 Americans died of reactions to the jabs. The study, published last week in BMC Infectious Diseases, used Dynata, the world’s largest first-party data platform, to create a random sample of 2,840 Americans to report their experience with the shots: 15% of those surveyed indicated they had experienced a health issue after vaccination, and 13% of those indicated that a severe adverse event had occurred, in line with many other surveys.

Using extrapolations from the survey juxtaposed to state-by-state VAERS deaths, the researcher estimates that, as of Dec. 18, 2021, there were a total of 278,000 vaccine fatalities in the U.S. Further, “severe” adverse events are estimated to be about one million nationwide, and “less severe” adverse events are about 2.1 million. Estimated nationwide fatalities, “severe” injuries, and “less severe” injuries tally to 3.4 million.

This is just after the first year of the vaccine. The results should shock the conscience of the public.

So how many died in the world over two years of vaccination? Using the numbers from Our World in Data, 493 million doses of the vaccine were administered in the U.S. at the time of the Michigan State survey. So, if 493 million doses were enough to kill 278 thousand Americans, how many would have died at the same rate globally from the beginning until today? At 13.24 billion doses administered globally, that would result in 7.47 million vaccine fatalities, more than the Holocaust! That would be in addition to 27 million severe injuries globally!

What is shockingly eerie about this projection is that it’s almost identical to what I estimated in terms of the global death toll two months ago based on the CDC’s V-SAFE data demonstrating an underreporting factor in VAERS of 26. Using the URF of 26, and multiplying for the global doses administered, I estimated a back-of-the-envelope total of 7.855 million COVID shot deaths globally.

Using this extrapolation just for the U.S. based on the total current number of doses, it would work out to about 372,000 deaths in the U.S. Some estimate as many as 550,000 non-COVID excess deaths, which could demonstrate potentially an even higher death toll. Keep in mind that the Michigan State study was just of the first year of shots, which was composed mainly of the original doses. Many scientists critical of the jabs believe there is a strong dose dependence associated with fatalities. It’s thus reasonable to assume that the fatality rate per dose over the past year, which was composed mainly of boosters and even multiple booster doses per person, might have been higher. It’s also possible that with another year of data beyond this survey, we would begin actualizing long-term deaths associated with the shots.


https://www.conservativereview.com/horowitz-d...20Combined
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 1

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 4

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 0

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 4

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 0

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 0

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 45

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
ection End -->

Top 5 Most Recently Viewed Articles

Revolutionizing Views: Space Needle's New Otis Elevators

Updated Category News Views 169

Space Needle Unveils Modern Otis Double-Deck Elevators In a significant upgrade to enhance visitor experiences, the Space Needle has launched its first Otis double-deck glass elevator. This innovative lift is part of a larger project to modernize three elevators at the iconic structure, providing a unique ride with stunning panoramic views. A First Look at the Innovative...

Continue Reading
Key Insights from the Upcoming Press Conference on Assault Case

Updated Category News Views 199

Important Press Conference on Recent Assault Case Attorneys from Matheson & Associates, PLLC are set to hold an impactful press conference aimed at shedding light on a serious incident involving truck drivers engaged in Hurricane Helene cleanup efforts. This incident has raised significant concerns about safety and racial tensions. Understanding the Incident On an...

Continue Reading
Couche-Tard Clarifies Intentions Amid Seven & i Interest

Updated Category News Views 255

Alimentation Couche-Tard Addresses Acquisition Negotiations In recent discussions reported by Japanese media, Alimentation Couche-Tard has made it clear that they are not pursuing a hostile takeover of Seven & i Holdings. Chairman Alain Bouchard emphasized that their strategy focuses on securing a collaborative acquisition approach, rather than a forced or antagonistic...

Continue Reading
Legend Biotech Maintains Strong Outlook Despite Sales Fluctuations

Updated Category News Views 97

Overview of Legend Biotech's Market Performance Legend Biotech Corp. (NASDAQ: LEGN) has been the focus of investor attention lately, with analysts maintaining a Buy rating and a price target of $91. This confidence stems from recent sales data for CARVYKTI, a treatment for multiple myeloma, which saw impressive performance in its latest quarter. CARVYKTI Sales Surpass...

Continue Reading
Transforming Alzheimer's Diagnostics: New Guidelines Unveiled

Updated Category News Views 111

New Era in Alzheimer's Disease Diagnosis In a significant advancement for the diagnosis of Alzheimer’s disease and related cognitive impairments, a comprehensive set of clinical practice guidelines has been introduced, marking a pivotal moment for both primary and specialty care. This newly established guideline serves as a beacon for healthcare providers, ensuring they...

Continue Reading